Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 84

Similar articles for PubMed (Select 23334589)

1.

Targetome profiling, pathway analysis and genetic association study implicate miR-202 in lymphomagenesis.

Hoffman AE, Liu R, Fu A, Zheng T, Slack F, Zhu Y.

Cancer Epidemiol Biomarkers Prev. 2013 Mar;22(3):327-36. doi: 10.1158/1055-9965.EPI-12-1131-T. Epub 2013 Jan 18.

2.

Targetome profiling and functional genetics implicate miR-618 in lymphomagenesis.

Fu A, Hoffman AE, Liu R, Jacobs DI, Zheng T, Zhu Y.

Epigenetics. 2014 May;9(5):730-7. doi: 10.4161/epi.27996. Epub 2014 Feb 6.

3.

microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis.

Hoffman AE, Zheng T, Yi C, Leaderer D, Weidhaas J, Slack F, Zhang Y, Paranjape T, Zhu Y.

Cancer Res. 2009 Jul 15;69(14):5970-7. doi: 10.1158/0008-5472.CAN-09-0236. Epub 2009 Jun 30. Erratum in: Cancer Res. 2009 Aug 15;69(16):6758.

4.

A systematic analysis of miRNA transcriptome in Marek's disease virus-induced lymphoma reveals novel and differentially expressed miRNAs.

Lian L, Qu L, Chen Y, Lamont SJ, Yang N.

PLoS One. 2012;7(11):e51003. doi: 10.1371/journal.pone.0051003. Epub 2012 Nov 30.

5.

A functional TNFRSF5 polymorphism and risk of non-Hodgkin lymphoma, a pooled analysis.

Nieters A, Bracci PM, de Sanjosé S, Becker N, Maynadié M, Benavente Y, Foretova L, Cocco P, Staines A, Holly EA, Boffetta P, Brennan P, Skibola CF.

Int J Cancer. 2011 Mar 15;128(6):1481-5. doi: 10.1002/ijc.25420.

6.

Gene expression profiling in whole blood of patients with coronary artery disease.

Taurino C, Miller WH, McBride MW, McClure JD, Khanin R, Moreno MU, Dymott JA, Delles C, Dominiczak AF.

Clin Sci (Lond). 2010 Jul 9;119(8):335-43. doi: 10.1042/CS20100043.

7.

Clock-cancer connection in non-Hodgkin's lymphoma: a genetic association study and pathway analysis of the circadian gene cryptochrome 2.

Hoffman AE, Zheng T, Stevens RG, Ba Y, Zhang Y, Leaderer D, Yi C, Holford TR, Zhu Y.

Cancer Res. 2009 Apr 15;69(8):3605-13. doi: 10.1158/0008-5472.CAN-08-4572. Epub 2009 Mar 24.

8.

A high throughput experimental approach to identify miRNA targets in human cells.

Tan LP, Seinen E, Duns G, de Jong D, Sibon OC, Poppema S, Kroesen BJ, Kok K, van den Berg A.

Nucleic Acids Res. 2009 Nov;37(20):e137. doi: 10.1093/nar/gkp715. Epub 2009 Sep 4.

9.

No association of pre-microRNA-146a rs2910164 polymorphism and risk of hepatocellular carcinoma development in Turkish population: a case-control study.

Akkız H, Bayram S, Bekar A, Akgöllü E, Usküdar O, Sandıkçı M.

Gene. 2011 Oct 15;486(1-2):104-9. doi: 10.1016/j.gene.2011.07.006. Epub 2011 Jul 23.

PMID:
21807077
10.

Discrepant expression of microRNAs in transparent and cataractous human lenses.

Wu C, Lin H, Wang Q, Chen W, Luo H, Chen W, Zhang H.

Invest Ophthalmol Vis Sci. 2012 Jun 22;53(7):3906-12. doi: 10.1167/iovs.11-9178.

PMID:
22562507
11.

A deep investigation into the adipogenesis mechanism: profile of microRNAs regulating adipogenesis by modulating the canonical Wnt/beta-catenin signaling pathway.

Qin L, Chen Y, Niu Y, Chen W, Wang Q, Xiao S, Li A, Xie Y, Li J, Zhao X, He Z, Mo D.

BMC Genomics. 2010 May 23;11:320. doi: 10.1186/1471-2164-11-320.

12.

Specific sequence determinants of miR-15/107 microRNA gene group targets.

Nelson PT, Wang WX, Mao G, Wilfred BR, Xie K, Jennings MH, Gao Z, Wang X.

Nucleic Acids Res. 2011 Oct;39(18):8163-72. doi: 10.1093/nar/gkr532. Epub 2011 Jun 30.

13.

MicroRNA-148b enhances the radiosensitivity of non-Hodgkin's Lymphoma cells by promoting radiation-induced apoptosis.

Wu Y, Liu GL, Liu SH, Wang CX, Xu YL, Ying Y, Mao P.

J Radiat Res. 2012 Jul;53(4):516-25. doi: 10.1093/jrr/rrs002. Epub 2012 Jun 6.

14.

MicroRNA-200 is commonly repressed in conjunctival MALT lymphoma, and targets cyclin E2.

Cai J, Liu X, Cheng J, Li Y, Huang X, Li Y, Ma X, Yu H, Liu H, Wei R.

Graefes Arch Clin Exp Ophthalmol. 2012 Apr;250(4):523-31. doi: 10.1007/s00417-011-1885-4. Epub 2011 Dec 20.

PMID:
22183793
15.

MicroRNA profiling of follicular lymphoma identifies microRNAs related to cell proliferation and tumor response.

Wang W, Corrigan-Cummins M, Hudson J, Maric I, Simakova O, Neelapu SS, Kwak LW, Janik JE, Gause B, Jaffe ES, Calvo KR.

Haematologica. 2012 Apr;97(4):586-94. doi: 10.3324/haematol.2011.048132. Epub 2011 Nov 18.

16.

Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer.

Jalava SE, Urbanucci A, Latonen L, Waltering KK, Sahu B, Jänne OA, Seppälä J, Lähdesmäki H, Tammela TL, Visakorpi T.

Oncogene. 2012 Oct 11;31(41):4460-71. doi: 10.1038/onc.2011.624. Epub 2012 Jan 23.

PMID:
22266859
17.

Target identification of microRNAs expressed highly in human embryonic stem cells.

Li SS, Yu SL, Kao LP, Tsai ZY, Singh S, Chen BZ, Ho BC, Liu YH, Yang PC.

J Cell Biochem. 2009 Apr 15;106(6):1020-30. doi: 10.1002/jcb.22084.

PMID:
19229866
18.

Identification and characteristics of microRNAs from Bombyx mori.

He PA, Nie Z, Chen J, Chen J, Lv Z, Sheng Q, Zhou S, Gao X, Kong L, Wu X, Jin Y, Zhang Y.

BMC Genomics. 2008 May 28;9:248. doi: 10.1186/1471-2164-9-248.

19.

MicroRNA expression profiling reveals the potential function of microRNA-31 in chordomas.

Bayrak OF, Gulluoglu S, Aydemir E, Ture U, Acar H, Atalay B, Demir Z, Sevli S, Creighton CJ, Ittmann M, Sahin F, Ozen M.

J Neurooncol. 2013 Nov;115(2):143-51. doi: 10.1007/s11060-013-1211-6. Epub 2013 Aug 3.

PMID:
23912551
20.

Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro.

Dyrskjøt L, Ostenfeld MS, Bramsen JB, Silahtaroglu AN, Lamy P, Ramanathan R, Fristrup N, Jensen JL, Andersen CL, Zieger K, Kauppinen S, Ulhøi BP, Kjems J, Borre M, Orntoft TF.

Cancer Res. 2009 Jun 1;69(11):4851-60. doi: 10.1158/0008-5472.CAN-08-4043.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk